Results 161 to 170 of about 8,038 (216)

Imaging signatures of eosinophilic granulomatosis with polyangiitis-related myocarditis: A case report. [PDF]

Radiol Case Rep
Lamassab NEH, Merimi I, Nabila I, Noha EO, Zakaria B.   +4 more
europepmc   +1 more source

Mechanisms, clinical manifestations and management of cardiovascular diseases in ANCA-associated vasculitis. [PDF]

Rheumatology (Oxford)
Chiara E, Bagni G, Raho A, Fagni F, Mohammad AJ, Emmi G.   +5 more
europepmc   +1 more source

Eosinophilic Granulomatosis With Polyangiitis (EGPA) Manifesting as Giant Cell Arteritis After Initiating Treatment With Dupilumab: An Unusual Clinical Presentation. [PDF]

Cureus
Zafar S, Medina E, Panesar R, Murthy VL.
europepmc   +1 more source

Toward a Quality Open Government Data Ecosystem: Actors and practices

, 2019
SANTIS, Serena, COGO, GIANLUIGI, Marco BISOGNO, Gianluigi COGO, BISOGNO, MARCO, Serena SANTIS, Giovanni VAIA, VAIA, Giovanni   +7 more
core  

Recurrent Cutaneous Eosinophilic Vasculitis: A Systematic Review of Clinicopathologic Features and Treatment Outcomes. [PDF]

Acta Derm Venereol
Iinuma S, Kobayashi T, Fujita Y.
europepmc   +1 more source

Steroid-Free Remission of Eosinophilic Granulomatosis With Polyangiitis Achieved With Low-Dose Mepolizumab: A Case Report. [PDF]

Clin Case Rep
Matsuoka S, Takigawa Y, Nishimura J, Watanabe H, Kudo K, Sato K, Fujiwara K, Shibayama T.   +7 more
europepmc   +1 more source

EGPA Phenotyping: Not Only ANCA, but Also Eosinophils [PDF]

Biomedicines, 2023
Background: Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a small-vessel necrotizing vasculitis. The anti-neutrophil cytoplasmic antibodies’ (ANCA) role in defining clinical EGPA phenotypes is well established. Although the role of eosinophils in disease pathogenesis has been clearly demonstrated, the value of blood eosinophil count (BEC) as ...
Lorenzo Cosmi, Andrea Matucci, Alessandra Vultaggio   +2 more
exaly   +5 more sources

ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics [PDF]

Frontiers in Immunology, 2023
The pathogenic role of p-ANCA in eosinophilic granulomatosis with polyangiitis (EGPA) is a long-standing matter of debate. In this work, we report our real-life experience with EGPA patients, treated with biologics targeting type 2 (T2)-eosinophilic ...
Paolo Fraticelli, Matteo Martini, Leonardo Antonicelli   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Childhood GPA, EGPA, and MPA

Clinical Immunology, 2020
Antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) is a term used to describe rare primary systemic vasculitides affecting small and medium-sized blood vessels. AAV diseases which include Granulomatosis with Polyangiitis (GPA), Eosinophilic Granulomatosis with Polyangiitis (EGPA), Microscopic Polyangiitis (MPA) and renal limited ANCA ...
Mehul, Jariwala, Ronald M, Laxer
openaire   +2 more sources

Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study [PDF]

Journal of Autoimmunity
Following the results of the MANDARA trial, this real-life study aimed at comparing the effectiveness and safety profile of mepolizumab versus benralizumab in a European EGPA cohort.
Del Giacco, Georgina Espigol Frigolé, Pavel Novikov   +2 more
exaly   +3 more sources